AzTrials
AzTrials

Hip OsteoarthritisDROMDPNCT02047292

Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters

A study testing THA Corail PinnacleCoC28, THA Corail DeltaMotion36 and THA Corail DeltaMotion40 in people with Hip Osteoarthritis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pain and reduced function are the most common symptoms of coxarthritis. Pain relief and normal range of motion (ROM) restoration are the objectives of a Total Hip Arthroplasty (THA) procedure. Read more about this study

Who is it for?
Ages 35 to 55 years
Conditions the study is for
Hip Osteoarthritis
What is being tested?
THA Corail PinnacleCoC28, THA Corail DeltaMotion36 and THA Corail DeltaMotion40
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
Jan 2014to 21 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with unilateral primary or secondary hip arthrosis indicated for THA;
  • Men and female, age between 35 and 55 years old;
  • BMI smaller than 30;
  • Patients able to understand the protocol and to sign the informed consent.

Who cannot join

  • Child-bearing female;
  • Patients with also controlateral hip arthritis;
  • Neurological patients, because of possible alteration of neuro-muscular control of the replaced hip;
  • Patients treated with joint replacement at any other lower limb articulation

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Istituto Ortopedico Rizzoli

    Bologna, BO, 40136

Other trials in Italy

About this study

Official title: Dynamic Range of Motion (ROM) Assessment Using Gait Analysis and Three-dimensional Fluoroscopy in Patients Treated by Total Hip Arthroplasty (THA) With Different Head Diameters

Pain and reduced function are the most common symptoms of coxarthritis. Pain relief and normal range of motion (ROM) restoration are the objectives of a Total Hip Arthroplasty (THA) procedure. It is recognized that increased head-neck ratio results in increased ROM due to the fact that prosthetic impingement between neck and acetabular liner occurs with wider arcs of motion. This head-neck ratio has been investigated extensively only in vitro (on cadavers or sawbones) or using mathematical modeling in computer simulations. These studies are limited by the lack of soft tissues and muscle activations in the models. This study will clinically assess the effect of prosthetic head diameter on patient capability of performing movements which require extreme arcs of motion of the hip joint. Therefore, the research questions are:

  • What role do soft tissues play in limiting ROM?
  • Can prosthetic impingement really occur in a well positioned THA?
  • Can a bigger head diameter alone reduce the risk of impingement?
Read the detailed description

This will be a prospective comparative randomized double-blind Study (both patient and the clinical engineer performing the gait analysis will be blind with respect to the prosthetic head diameter implanted). Patient recruitment will last 12 months and the Study will have a follow-up period of 12 months. A total number of 45 patients will be recruited. Patients will be randomly allocated into three groups: the first group will undergo THA with a 28mm diameter head (Pinnacle Acetabular System, with a ceramic on ceramic - CoC - bearing), in the second group THA will be performed using a 36 mm diameter head (DeltaMotion), finally patients in the third group will undergo THA with a 40 mm diameter head (DeltaMotion). Patients will be operated by three surgeons of the same hospital according to the same surgical procedure and using the same direct lateral approach. All patients will receive a Corail stem and will follow the same rehabilitation program.

  • Primary endpoint: Gait analysis and fluoroscopy will provide quantitative information of prosthesis in vivo performance, e.g. what is the arc (degrees) of active or passive motion when prosthetic impingement occurs?
  • Secondary endpoint(s): these analyses will also allow to: 1) assess ROM of the operated hip versus contralateral non operated hip and the effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature; 2) set reproducible criteria for in vivo fluoroscopic analysis of ROM in THA patients.
Being tested
THA Corail PinnacleCoC28, THA Corail DeltaMotion36, THA Corail DeltaMotion40
Keywords
Gait analysis, 3D videofluoroscopy, Femoroacetabular impingement, Neck-cup impingement, Head-neck ratio, Hip scores, Functional assessment, Cup size, Range of motion, Unilateral Primary, Secondary
Medical subject headings
Osteoarthritis, Hip, Femoracetabular Impingement, Neoplasm Metastasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • THA Corail PinnacleCoC28Device

    Uncemented THA with Corail stem and Pinnacle acetabular cup with CoC 28 mm head

  • THA Corail DeltaMotion36Device

    Uncemented THA with Corail stem and DeltaMotion acetabular cup with 36 mm head

  • THA Corail DeltaMotion40Device

    Uncemented THA with Corail stem and DeltaMotion acetabular cup with 40 mm head

Study groups in NCT02047292
Study groupRoleWhat they receive
THA28Active comparatorTHA Corail PinnacleCoC28
Receives: Device: THA Corail PinnacleCoC28
THA36Active comparatorTHA Corail DeltaMotion36
Receives: Device: THA Corail DeltaMotion36
THA40Active comparatorTHA Corail DeltaMotion40
Receives: Device: THA Corail DeltaMotion40

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants and Hip Joint Positions with the Occurrence of Implant Impingement

    Three-dimension videofluoroscopy is used to calculate prosthesis component relative pose, and to estimate minimum distance at the areas of risk of impingement

    Measured: 12 months

  2. Number of Participants with Functional Deficits at the Hip Joint as Measured by Gait Analysis

    Three-dimension kinematics and kinetics of the trunk, pelvis and lower limb joints is used during level walking and other motor tasks, as well as for the single exercises of hip joint extreme motion analyzed in videofluoroscopy, to assess thoroughly those patients with and without impingement.

    Measured: 12 months

Secondary outcomes (4)
  1. Range of Motion of the operated hip versus contralateral non-operated hip

    Standard clinical range of motion at the two hips

    Measured: 12 months

  2. Correlations between prosthetic head diameter and hip functional scores

    The effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature

    Measured: 12 months

  3. Standard Clinical Hip Scores

    Outcomes: Harris Hip Score, Oxford Hip Score, WOMAC, Forgotten Joint score and UCLA activity score will be assessed and recorded pre-operatively and post-operatively at one year after surgery.

    Measured: pre-op, and 12 months

  4. X-ray measurements

    Radiographic assessment will also be performed at one year after surgery to assess implant position and osteointegration

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2014 (estimated)
  2. Study startJan 2014
  3. Primary completionFeb 2016
  4. Study completion21 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02047292
Sponsor's protocol ID
IORDePuyD57613
Acronym
DROMDP
Status last verified
Feb 2020
First submitted
22 Jan 2014
Last updated
17 Feb 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing THA Corail PinnacleCoC28, THA Corail DeltaMotion36 and THA Corail DeltaMotion40 in people with Hip Osteoarthritis, run by Istituto Ortopedico Rizzoli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants and Hip Joint Positions with the Occurrence of Implant Impingement (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in